California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, November 26, 2024

A California-based biotech company is already stealing the show so far during Tuesday’s premarket hours after it was announced that the company will be acquired by Roche in a $1.5 billion deal, with stockholders receiving up to $13 per share in cash.

Seeing that Poseida Therapeutics Inc. (Nasdaq:PSTX) closed at just $2.86/share yesterday, it’s no wonder that traders are rushing to get their hands on the small cap. At the time of writing, traders are currently bid at $9.36/share (+227.27% implied open for sellers). It should be an exciting session for this healthcare stock!

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Acquisition News Sends Micro-Cap Rallying Over 70%

This Biotech Stole The Show Following Securities Purchase Agreement Announcement

This Healthcare Stock Massively Outperformed The Market Before The Holiday

New York-Based Tech Stock Finds Massive Mid-Week Success

Shares Higher As Company Bridges the Gap Between AI, Quantum and Crypto

National Security Committee Forgoes Decision on U.S. Steel Acquisition

Toyota is donating US$1 million to Trump's inauguration

AllPennyStocks.com Favorites

Alaska Governor Urges Trump to Reverse Biden's Resource Policies

Enable Free Access to Unlock Up to Two Articles Per Month.

Equities End Week Lower as Fed Cuts Rates But Signals A Slower Path for 2025

Enable Free Access to Unlock Up to Two Articles Per Month.

BlackBerry Limited looks promising from a technical analysis perspective as the New York Stock Exchange listed stock displayed what technicians call a Golden Cross (50 DMA / 200 DMA) on Tuesday. Shares closed at $3.96.

TSX-Venture traded, Tuktu Resources Ltd. took off in Tuesday's trading session. Shares climbed an impressive 150.00%, ending the day at $0.05.

Trading on the OTC Markets, LILMF rallied 268.00%, closing at $0.14 on Tuesday.

Dually-Listed Junior Miner Sets Up For Major Rally

Enable Free Access to Unlock Up to Two Articles Per Month.

This Micro Cap Is Setting Up For A Strong EOY Finish

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●"By The Numbers" Data Analytics

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement

Other Penny Stock Movers

Acquisition News Sends Micro-Cap Rallying Over 70%

This Biotech Stole The Show Following Securities Purchase Agreement Announcement

This Healthcare Stock Massively Outperformed The Market Before The Holiday

Most Popular

AllPennyStocks.com Favorites